-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cti Biopharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
- Cti Biopharma Corp Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$4.19M, a 102% decline year-over-year.
- Cti Biopharma Corp Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$15.3M, a 244% decline year-over-year.
- Cti Biopharma Corp annual Nonoperating Income (Expense) for 2022 was -$13.2M, a 412% decline from 2021.
- Cti Biopharma Corp annual Nonoperating Income (Expense) for 2021 was -$2.58M, a 45% increase from 2020.
- Cti Biopharma Corp annual Nonoperating Income (Expense) for 2020 was -$4.68M, a 781% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)